Sopharma AD (WSE:SPH)

Sopharma AD Statistics

Total Valuation

Sopharma AD has a market cap or net worth of PLN 2.98 billion. The enterprise value is 4.33 billion.

Market Cap	2.98B
Enterprise Value	4.33B

Important Dates

The last earnings date was Saturday, August 30, 2025.

Earnings Date	Aug 30, 2025
Ex-Dividend Date	Jul 10, 2025

Share Statistics

Current Share Class	499.09M
Shares Outstanding	n/a
Shares Change (YoY)	+4.07%
Shares Change (QoQ)	+1.50%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	126.96M

Valuation Ratios

The trailing PE ratio is 13.40.

PE Ratio	13.40
Forward PE	n/a
PS Ratio	0.57
PB Ratio	1.48
P/TBV Ratio	2.17
P/FCF Ratio	n/a
P/OCF Ratio	43.16
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.14, with an EV/FCF ratio of -370.55.

EV / Earnings	19.49
EV / Sales	0.83
EV / EBITDA	10.14
EV / EBIT	14.77
EV / FCF	-370.55

Financial Position

The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.67.

Current Ratio	1.30
Quick Ratio	0.68
Debt / Equity	0.67
Debt / EBITDA	3.94
Debt / FCF	-115.95
Interest Coverage	5.68

Financial Efficiency

Return on equity (ROE) is 12.55% and return on invested capital (ROIC) is 4.43%.

Return on Equity (ROE)	12.55%
Return on Assets (ROA)	3.50%
Return on Invested Capital (ROIC)	4.43%
Return on Capital Employed (ROCE)	8.08%
Revenue Per Employee	887,636
Profits Per Employee	37,676
Employee Count	5,599
Asset Turnover	1.40
Inventory Turnover	4.49

Taxes

In the past 12 months, Sopharma AD has paid 31.36 million in taxes.

Income Tax	31.36M
Effective Tax Rate	11.65%

Stock Price Statistics

The stock price has decreased by -11.46% in the last 52 weeks. The beta is -0.15, so Sopharma AD's price volatility has been lower than the market average.

Beta (5Y)	-0.15
52-Week Price Change	-11.46%
50-Day Moving Average	11.82
200-Day Moving Average	12.76
Relative Strength Index (RSI)	51.65
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sopharma AD had revenue of PLN 5.23 billion and earned 222.10 million in profits. Earnings per share was 0.44.

Revenue	5.23B
Gross Profit	1.16B
Operating Income	209.94M
Pretax Income	269.09M
Net Income	222.10M
EBITDA	298.58M
EBIT	209.94M
Earnings Per Share (EPS)	0.44

Balance Sheet

The company has 74.94 million in cash and 1.35 billion in debt, giving a net cash position of -1.28 billion.

Cash & Cash Equivalents	74.94M
Total Debt	1.35B
Net Cash	-1.28B
Net Cash Per Share	n/a
Equity (Book Value)	2.01B
Book Value Per Share	3.80
Working Capital	501.47M

Cash Flow

In the last 12 months, operating cash flow was 68.97 million and capital expenditures -80.65 million, giving a free cash flow of -11.68 million.

Operating Cash Flow	68.97M
Capital Expenditures	-80.65M
Free Cash Flow	-11.68M
FCF Per Share	n/a

Margins

Gross margin is 22.09%, with operating and profit margins of 4.01% and 4.24%.

Gross Margin	22.09%
Operating Margin	4.01%
Pretax Margin	5.14%
Profit Margin	4.24%
EBITDA Margin	5.71%
EBIT Margin	4.01%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.23, which amounts to a dividend yield of 1.80%.

Dividend Per Share	0.23
Dividend Yield	1.80%
Dividend Growth (YoY)	-68.55%
Years of Dividend Growth	n/a
Payout Ratio	27.13%
Buyback Yield	-4.07%
Shareholder Yield	-2.27%
Earnings Yield	7.46%
FCF Yield	-0.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 10, 2025. It was a forward split with a ratio of 3.

Last Split Date	Jul 10, 2025
Split Type	Forward
Split Ratio	3

Scores

Sopharma AD has an Altman Z-Score of 2.61 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.61
Piotroski F-Score	5